Shamburg News · 8-K filed Nov 5, 2026, 4:15 PM EST
Profound Medical Reports Q3 2026 Revenue of $9.8 Million and Announces CEO Succession
PROF · Profound Medical Corp.
- Earnings
- Leadership change
- Materiality: high
Profound Medical Corp. reported financial results for the quarter ended September 30, 2026, with total revenue of approximately $9.8 million, up 86% year-over-year, and a net loss of approximately $7.7 million, or $0.21 per common share. The company projects full-year 2026 revenue of at least $25.0 million. Richard Fabian will succeed Arun Menawat as CEO effective January 14, 2027, Matthew Sobczyk was appointed permanent CFO, and Jason Mills was appointed to the Board.
Source: SEC EDGAR, Form 8-K, Items 2.02, 5.02, 9.01, accession 0001171843-26-007182.
Written from the filing by Shamburg Markets. Figures are as reported by the company.